MEJan 18, 2023
Non-parametric identifiability and sensitivity analysis of synthetic control modelsJakob Zeitler, Athanasios Vlontzos, Ciaran M. Gilligan-Lee
Quantifying cause and effect relationships is an important problem in many domains. The gold standard solution is to conduct a randomised controlled trial. However, in many situations such trials cannot be performed. In the absence of such trials, many methods have been devised to quantify the causal impact of an intervention from observational data given certain assumptions. One widely used method are synthetic control models. While identifiability of the causal estimand in such models has been obtained from a range of assumptions, it is widely and implicitly assumed that the underlying assumptions are satisfied for all time periods both pre- and post-intervention. This is a strong assumption, as synthetic control models can only be learned in pre-intervention period. In this paper we address this challenge, and prove identifiability can be obtained without the need for this assumption, by showing it follows from the principle of invariant causal mechanisms. Moreover, for the first time, we formulate and study synthetic control models in Pearl's structural causal model framework. Importantly, we provide a general framework for sensitivity analysis of synthetic control causal inference to violations of the assumptions underlying non-parametric identifiability. We end by providing an empirical demonstration of our sensitivity analysis framework on simulated and real data in the widely-used linear synthetic control framework.
MLNov 28, 2024
Contrastive representations of high-dimensional, structured treatmentsOriol Corcoll Andreu, Athanasios Vlontzos, Michael O'Riordan et al.
Estimating causal effects is vital for decision making. In standard causal effect estimation, treatments are usually binary- or continuous-valued. However, in many important real-world settings, treatments can be structured, high-dimensional objects, such as text, video, or audio. This provides a challenge to traditional causal effect estimation. While leveraging the shared structure across different treatments can help generalize to unseen treatments at test time, we show in this paper that using such structure blindly can lead to biased causal effect estimation. We address this challenge by devising a novel contrastive approach to learn a representation of the high-dimensional treatments, and prove that it identifies underlying causal factors and discards non-causally relevant factors. We prove that this treatment representation leads to unbiased estimates of the causal effect, and empirically validate and benchmark our results on synthetic and real-world datasets.
LGSep 4, 2021
Estimating Categorical Counterfactuals via Deep Twin NetworksAthanasios Vlontzos, Bernhard Kainz, Ciaran M. Gilligan-Lee
Counterfactual inference is a powerful tool, capable of solving challenging problems in high-profile sectors. To perform counterfactual inference, one requires knowledge of the underlying causal mechanisms. However, causal mechanisms cannot be uniquely determined from observations and interventions alone. This raises the question of how to choose the causal mechanisms so that resulting counterfactual inference is trustworthy in a given domain. This question has been addressed in causal models with binary variables, but the case of categorical variables remains unanswered. We address this challenge by introducing for causal models with categorical variables the notion of counterfactual ordering, a principle that posits desirable properties causal mechanisms should posses, and prove that it is equivalent to specific functional constraints on the causal mechanisms. To learn causal mechanisms satisfying these constraints, and perform counterfactual inference with them, we introduce deep twin networks. These are deep neural networks that, when trained, are capable of twin network counterfactual inference -- an alternative to the abduction, action, & prediction method. We empirically test our approach on diverse real-world and semi-synthetic data from medicine, epidemiology, and finance, reporting accurate estimation of counterfactual probabilities while demonstrating the issues that arise with counterfactual reasoning when counterfactual ordering is not enforced.